[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antiserum Market Research Report 2024(Status and Outlook)

May 2024 | 132 pages | ID: G911544C015AEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.

Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.

Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.

The Global Antiserum Market Size was estimated at USD 1414.24 million in 2023 and is projected to reach USD 2098.70 million by 2029, exhibiting a CAGR of 6.80% during the forecast period.

This report provides a deep insight into the global Antiserum market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antiserum Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antiserum market in any manner.

Global Antiserum Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

BD

Bio-Rad

Shanghai Serum Bio-Technology Co., Ltd.

China National Pharmaceutical Group

CSL

Merck

BTG

Pfizer

Haffkine Bio-Pharmaceutical

Vins Bioproducts

Bharat Serums and Vaccines

SSI Diagnostica

GD Animal Health

MicroPharm

Peptide Institute Inc.

Rare Disease Therapeutics

Market Segmentation (by Type)

Antitoxin Serum

Antibacterial Serum

Antiviral Serum

Others

Market Segmentation (by Application)

Clinical

Laboratory

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Antiserum Market
  • Overview of the regional outlook of the Antiserum Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiserum Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Antiserum
1.2 Key Market Segments
  1.2.1 Antiserum Segment by Type
  1.2.2 Antiserum Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ANTISERUM MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Antiserum Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Antiserum Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ANTISERUM MARKET COMPETITIVE LANDSCAPE

3.1 Global Antiserum Sales by Manufacturers (2019-2024)
3.2 Global Antiserum Revenue Market Share by Manufacturers (2019-2024)
3.3 Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antiserum Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antiserum Sales Sites, Area Served, Product Type
3.6 Antiserum Market Competitive Situation and Trends
  3.6.1 Antiserum Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Antiserum Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 ANTISERUM INDUSTRY CHAIN ANALYSIS

4.1 Antiserum Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ANTISERUM MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 ANTISERUM MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiserum Sales Market Share by Type (2019-2024)
6.3 Global Antiserum Market Size Market Share by Type (2019-2024)
6.4 Global Antiserum Price by Type (2019-2024)

7 ANTISERUM MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiserum Market Sales by Application (2019-2024)
7.3 Global Antiserum Market Size (M USD) by Application (2019-2024)
7.4 Global Antiserum Sales Growth Rate by Application (2019-2024)

8 ANTISERUM MARKET SEGMENTATION BY REGION

8.1 Global Antiserum Sales by Region
  8.1.1 Global Antiserum Sales by Region
  8.1.2 Global Antiserum Sales Market Share by Region
8.2 North America
  8.2.1 North America Antiserum Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Antiserum Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Antiserum Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Antiserum Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Antiserum Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 BD
  9.1.1 BD Antiserum Basic Information
  9.1.2 BD Antiserum Product Overview
  9.1.3 BD Antiserum Product Market Performance
  9.1.4 BD Business Overview
  9.1.5 BD Antiserum SWOT Analysis
  9.1.6 BD Recent Developments
9.2 Bio-Rad
  9.2.1 Bio-Rad Antiserum Basic Information
  9.2.2 Bio-Rad Antiserum Product Overview
  9.2.3 Bio-Rad Antiserum Product Market Performance
  9.2.4 Bio-Rad Business Overview
  9.2.5 Bio-Rad Antiserum SWOT Analysis
  9.2.6 Bio-Rad Recent Developments
9.3 Shanghai Serum Bio-Technology Co., Ltd.
  9.3.1 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Basic Information
  9.3.2 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product Overview
  9.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product Market Performance
  9.3.4 Shanghai Serum Bio-Technology Co., Ltd. Antiserum SWOT Analysis
  9.3.5 Shanghai Serum Bio-Technology Co., Ltd. Business Overview
  9.3.6 Shanghai Serum Bio-Technology Co., Ltd. Recent Developments
9.4 China National Pharmaceutical Group
  9.4.1 China National Pharmaceutical Group Antiserum Basic Information
  9.4.2 China National Pharmaceutical Group Antiserum Product Overview
  9.4.3 China National Pharmaceutical Group Antiserum Product Market Performance
  9.4.4 China National Pharmaceutical Group Business Overview
  9.4.5 China National Pharmaceutical Group Recent Developments
9.5 CSL
  9.5.1 CSL Antiserum Basic Information
  9.5.2 CSL Antiserum Product Overview
  9.5.3 CSL Antiserum Product Market Performance
  9.5.4 CSL Business Overview
  9.5.5 CSL Recent Developments
9.6 Merck
  9.6.1 Merck Antiserum Basic Information
  9.6.2 Merck Antiserum Product Overview
  9.6.3 Merck Antiserum Product Market Performance
  9.6.4 Merck Business Overview
  9.6.5 Merck Recent Developments
9.7 BTG
  9.7.1 BTG Antiserum Basic Information
  9.7.2 BTG Antiserum Product Overview
  9.7.3 BTG Antiserum Product Market Performance
  9.7.4 BTG Business Overview
  9.7.5 BTG Recent Developments
9.8 Pfizer
  9.8.1 Pfizer Antiserum Basic Information
  9.8.2 Pfizer Antiserum Product Overview
  9.8.3 Pfizer Antiserum Product Market Performance
  9.8.4 Pfizer Business Overview
  9.8.5 Pfizer Recent Developments
9.9 Haffkine Bio-Pharmaceutical
  9.9.1 Haffkine Bio-Pharmaceutical Antiserum Basic Information
  9.9.2 Haffkine Bio-Pharmaceutical Antiserum Product Overview
  9.9.3 Haffkine Bio-Pharmaceutical Antiserum Product Market Performance
  9.9.4 Haffkine Bio-Pharmaceutical Business Overview
  9.9.5 Haffkine Bio-Pharmaceutical Recent Developments
9.10 Vins Bioproducts
  9.10.1 Vins Bioproducts Antiserum Basic Information
  9.10.2 Vins Bioproducts Antiserum Product Overview
  9.10.3 Vins Bioproducts Antiserum Product Market Performance
  9.10.4 Vins Bioproducts Business Overview
  9.10.5 Vins Bioproducts Recent Developments
9.11 Bharat Serums and Vaccines
  9.11.1 Bharat Serums and Vaccines Antiserum Basic Information
  9.11.2 Bharat Serums and Vaccines Antiserum Product Overview
  9.11.3 Bharat Serums and Vaccines Antiserum Product Market Performance
  9.11.4 Bharat Serums and Vaccines Business Overview
  9.11.5 Bharat Serums and Vaccines Recent Developments
9.12 SSI Diagnostica
  9.12.1 SSI Diagnostica Antiserum Basic Information
  9.12.2 SSI Diagnostica Antiserum Product Overview
  9.12.3 SSI Diagnostica Antiserum Product Market Performance
  9.12.4 SSI Diagnostica Business Overview
  9.12.5 SSI Diagnostica Recent Developments
9.13 GD Animal Health
  9.13.1 GD Animal Health Antiserum Basic Information
  9.13.2 GD Animal Health Antiserum Product Overview
  9.13.3 GD Animal Health Antiserum Product Market Performance
  9.13.4 GD Animal Health Business Overview
  9.13.5 GD Animal Health Recent Developments
9.14 MicroPharm
  9.14.1 MicroPharm Antiserum Basic Information
  9.14.2 MicroPharm Antiserum Product Overview
  9.14.3 MicroPharm Antiserum Product Market Performance
  9.14.4 MicroPharm Business Overview
  9.14.5 MicroPharm Recent Developments
9.15 Peptide Institute Inc.
  9.15.1 Peptide Institute Inc. Antiserum Basic Information
  9.15.2 Peptide Institute Inc. Antiserum Product Overview
  9.15.3 Peptide Institute Inc. Antiserum Product Market Performance
  9.15.4 Peptide Institute Inc. Business Overview
  9.15.5 Peptide Institute Inc. Recent Developments
9.16 Rare Disease Therapeutics
  9.16.1 Rare Disease Therapeutics Antiserum Basic Information
  9.16.2 Rare Disease Therapeutics Antiserum Product Overview
  9.16.3 Rare Disease Therapeutics Antiserum Product Market Performance
  9.16.4 Rare Disease Therapeutics Business Overview
  9.16.5 Rare Disease Therapeutics Recent Developments

10 ANTISERUM MARKET FORECAST BY REGION

10.1 Global Antiserum Market Size Forecast
10.2 Global Antiserum Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Antiserum Market Size Forecast by Country
  10.2.3 Asia Pacific Antiserum Market Size Forecast by Region
  10.2.4 South America Antiserum Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Antiserum by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Antiserum Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Antiserum by Type (2025-2030)
  11.1.2 Global Antiserum Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Antiserum by Type (2025-2030)
11.2 Global Antiserum Market Forecast by Application (2025-2030)
  11.2.1 Global Antiserum Sales (Kilotons) Forecast by Application
  11.2.2 Global Antiserum Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antiserum Market Size Comparison by Region (M USD)
Table 5. Global Antiserum Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antiserum Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antiserum Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antiserum Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2022)
Table 10. Global Market Antiserum Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antiserum Sales Sites and Area Served
Table 12. Manufacturers Antiserum Product Type
Table 13. Global Antiserum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antiserum
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiserum Market Challenges
Table 22. Global Antiserum Sales by Type (Kilotons)
Table 23. Global Antiserum Market Size by Type (M USD)
Table 24. Global Antiserum Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antiserum Sales Market Share by Type (2019-2024)
Table 26. Global Antiserum Market Size (M USD) by Type (2019-2024)
Table 27. Global Antiserum Market Size Share by Type (2019-2024)
Table 28. Global Antiserum Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antiserum Sales (Kilotons) by Application
Table 30. Global Antiserum Market Size by Application
Table 31. Global Antiserum Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antiserum Sales Market Share by Application (2019-2024)
Table 33. Global Antiserum Sales by Application (2019-2024) & (M USD)
Table 34. Global Antiserum Market Share by Application (2019-2024)
Table 35. Global Antiserum Sales Growth Rate by Application (2019-2024)
Table 36. Global Antiserum Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antiserum Sales Market Share by Region (2019-2024)
Table 38. North America Antiserum Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antiserum Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antiserum Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antiserum Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antiserum Sales by Region (2019-2024) & (Kilotons)
Table 43. BD Antiserum Basic Information
Table 44. BD Antiserum Product Overview
Table 45. BD Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. BD Business Overview
Table 47. BD Antiserum SWOT Analysis
Table 48. BD Recent Developments
Table 49. Bio-Rad Antiserum Basic Information
Table 50. Bio-Rad Antiserum Product Overview
Table 51. Bio-Rad Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bio-Rad Business Overview
Table 53. Bio-Rad Antiserum SWOT Analysis
Table 54. Bio-Rad Recent Developments
Table 55. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Basic Information
Table 56. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product Overview
Table 57. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Shanghai Serum Bio-Technology Co., Ltd. Antiserum SWOT Analysis
Table 59. Shanghai Serum Bio-Technology Co., Ltd. Business Overview
Table 60. Shanghai Serum Bio-Technology Co., Ltd. Recent Developments
Table 61. China National Pharmaceutical Group Antiserum Basic Information
Table 62. China National Pharmaceutical Group Antiserum Product Overview
Table 63. China National Pharmaceutical Group Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. China National Pharmaceutical Group Business Overview
Table 65. China National Pharmaceutical Group Recent Developments
Table 66. CSL Antiserum Basic Information
Table 67. CSL Antiserum Product Overview
Table 68. CSL Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. CSL Business Overview
Table 70. CSL Recent Developments
Table 71. Merck Antiserum Basic Information
Table 72. Merck Antiserum Product Overview
Table 73. Merck Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Merck Business Overview
Table 75. Merck Recent Developments
Table 76. BTG Antiserum Basic Information
Table 77. BTG Antiserum Product Overview
Table 78. BTG Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. BTG Business Overview
Table 80. BTG Recent Developments
Table 81. Pfizer Antiserum Basic Information
Table 82. Pfizer Antiserum Product Overview
Table 83. Pfizer Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. Haffkine Bio-Pharmaceutical Antiserum Basic Information
Table 87. Haffkine Bio-Pharmaceutical Antiserum Product Overview
Table 88. Haffkine Bio-Pharmaceutical Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Haffkine Bio-Pharmaceutical Business Overview
Table 90. Haffkine Bio-Pharmaceutical Recent Developments
Table 91. Vins Bioproducts Antiserum Basic Information
Table 92. Vins Bioproducts Antiserum Product Overview
Table 93. Vins Bioproducts Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vins Bioproducts Business Overview
Table 95. Vins Bioproducts Recent Developments
Table 96. Bharat Serums and Vaccines Antiserum Basic Information
Table 97. Bharat Serums and Vaccines Antiserum Product Overview
Table 98. Bharat Serums and Vaccines Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Bharat Serums and Vaccines Business Overview
Table 100. Bharat Serums and Vaccines Recent Developments
Table 101. SSI Diagnostica Antiserum Basic Information
Table 102. SSI Diagnostica Antiserum Product Overview
Table 103. SSI Diagnostica Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. SSI Diagnostica Business Overview
Table 105. SSI Diagnostica Recent Developments
Table 106. GD Animal Health Antiserum Basic Information
Table 107. GD Animal Health Antiserum Product Overview
Table 108. GD Animal Health Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. GD Animal Health Business Overview
Table 110. GD Animal Health Recent Developments
Table 111. MicroPharm Antiserum Basic Information
Table 112. MicroPharm Antiserum Product Overview
Table 113. MicroPharm Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. MicroPharm Business Overview
Table 115. MicroPharm Recent Developments
Table 116. Peptide Institute Inc. Antiserum Basic Information
Table 117. Peptide Institute Inc. Antiserum Product Overview
Table 118. Peptide Institute Inc. Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Peptide Institute Inc. Business Overview
Table 120. Peptide Institute Inc. Recent Developments
Table 121. Rare Disease Therapeutics Antiserum Basic Information
Table 122. Rare Disease Therapeutics Antiserum Product Overview
Table 123. Rare Disease Therapeutics Antiserum Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Rare Disease Therapeutics Business Overview
Table 125. Rare Disease Therapeutics Recent Developments
Table 126. Global Antiserum Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Antiserum Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Antiserum Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Antiserum Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Antiserum Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Antiserum Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Antiserum Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Antiserum Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Antiserum Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Antiserum Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Antiserum Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Antiserum Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Antiserum Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Antiserum Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Antiserum Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Antiserum Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Antiserum Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Antiserum
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiserum Market Size (M USD), 2019-2030
Figure 5. Global Antiserum Market Size (M USD) (2019-2030)
Figure 6. Global Antiserum Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiserum Market Size by Country (M USD)
Figure 11. Antiserum Sales Share by Manufacturers in 2023
Figure 12. Global Antiserum Revenue Share by Manufacturers in 2023
Figure 13. Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antiserum Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antiserum Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antiserum Market Share by Type
Figure 18. Sales Market Share of Antiserum by Type (2019-2024)
Figure 19. Sales Market Share of Antiserum by Type in 2023
Figure 20. Market Size Share of Antiserum by Type (2019-2024)
Figure 21. Market Size Market Share of Antiserum by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antiserum Market Share by Application
Figure 24. Global Antiserum Sales Market Share by Application (2019-2024)
Figure 25. Global Antiserum Sales Market Share by Application in 2023
Figure 26. Global Antiserum Market Share by Application (2019-2024)
Figure 27. Global Antiserum Market Share by Application in 2023
Figure 28. Global Antiserum Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antiserum Sales Market Share by Region (2019-2024)
Figure 30. North America Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antiserum Sales Market Share by Country in 2023
Figure 32. U.S. Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antiserum Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antiserum Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antiserum Sales Market Share by Country in 2023
Figure 37. Germany Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antiserum Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antiserum Sales Market Share by Region in 2023
Figure 44. China Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antiserum Sales and Growth Rate (Kilotons)
Figure 50. South America Antiserum Sales Market Share by Country in 2023
Figure 51. Brazil Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antiserum Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antiserum Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antiserum Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antiserum Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antiserum Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antiserum Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antiserum Market Share Forecast by Type (2025-2030)
Figure 65. Global Antiserum Sales Forecast by Application (2025-2030)
Figure 66. Global Antiserum Market Share Forecast by Application (2025-2030)


More Publications